OSI Pharmaceuticals

Companies OSI Pharmaceuticals

News OSI Pharmaceuticals

• MediGene appoints Arnd Christ as Chief Financial Officeras Successor to Dr. Thomas Klaue

  MediGene AG announced that Chief Financial Officer Dr. Thomas Klaue will leave the company for different opinions in strategic directions of the company by mutual consent with the Supervisory Board in May 2010. Dr. Klaue will resign from office after the Annual Shareholders' Meeting on May 11, 2010, more

• Pharminox appoints Scientific Advisory Board

  Pharminox Limited announced that it has completed the appointment of its Scientific Advisory Board to provide independent expert advice and guidance on the Company’s research and development portfolio. The inaugural members of the Pharminox Scientific Advisory Board will be Dr Lee Arnold, Professor more

• Dako announces a collaboration with OSI Pharmaceuticals, Inc. on Companion Diagnostics

  Dako has entered into a collaboration with OSI Pharmaceuticals, Inc. Under the terms of agreement, Dako and OSI Pharmaceuticals, Inc. will collaborate on developing a new cancer diagnostic test as a potential companion product for a cancer therapy. The new cancer diagnostic test is intended to iden more

Market studies OSI Pharmaceuticals

• Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors and GLP-1 Agonists

  GBI Research, the leading business intelligence provider, has released its latest research "Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors and GLP-1 Agonists" which provides insights into dia more

• World Anti-Obesity Drug Market 2011-2021

  What will this decade hold for the challenged anti-obesity drug industry and market? Our new report gives you revenue forecasts at world, product and national level. We provide original research, data and opinions to benefit your work. By ordering now, you can stay ahead. We aim to save you time a more

• Ophthalmic Drugs: World Market 2011-2021

  Where will the highest revenue growth occur in the ophthalmic drug market? Our new report shows you the eye disorder treatment market's potential from 2011 to 2021. We forecast and explain the commercial opportunities there. Our report gives you revenue predictions for ophthalmic treatments from 20 more

Websites OSI Pharmaceuticals